Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus
Aging Cell · 2024-09 · 23 (9)
DOI: 10.1111/acel.14239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 20.06.2024. Verfasst von Tahiyana Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Program in Neuroscience, Georgetown University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Status Epilepticus, Mice, Inbred C57BL, Seizures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Increased vulnerability to seizures in aging has been well documented both clinically and in various models of aging in epilepsy. Seizures can exacerbate cognitive decline that is already prominent in aging. Senescent cells are thought to contribute to cognitive impairment in aging and clearing senescent cells with senolytic drugs improves cognitive function in animal models. It remains unclear whether senescent cells render the aged brain vulnerable to seizures. Here, we demonstrate that prophylactic senolytic treatment with Dasatinib and Quercetin (D&Q) reduced both seizure severity and mortality in aged C57BL/6J mice. We subjected the D&Q and VEH‐treated aged mice to spatial memory testing before and after an acute seizure insult, Status Epilepticus [SE] , which leads to epilepsy development. We found that senolytic therapy improved spatial memory before injury, however, spatial memory was not rescued after SE . Senescence‐related proteins p16 and senescence‐associated β‐galactosidase were reduced in D&Q‐treated aged mice. Our findings indicate that senescent cells increase seizure susceptibility in aging. Thus, prophylactically targeting senescent cells may prevent age‐related seizure vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Program in Neuroscience, Georgetown University, Washington, District of Columbia, USA.
- Department of Pharmacology and Physiology, Georgetown University, Washington, District of Columbia, USA.
ORCID-Profile: Patrick A Forcelli
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute of General Medical Sciences
Zitieren
APA
Khan, T., Hussain, A. I., Casilli, T. P., Frayser, L., Cho, M., Williams, G., McFall, D., & Forcelli, P. A. (2024). Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus. Aging Cell, 23(9). https://doi.org/10.1111/acel.14239
Vancouver
Khan T, Hussain AI, Casilli TP, Frayser L, Cho M, Williams G, et al. Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus. Aging Cell. 2024;23(9). doi:10.1111/acel.14239
BibTeX
@article{Khan2024,
author = {Khan, Tahiyana and Hussain, Abbas I and Casilli, Timothy P and Frayser, Logan and Cho, Michelle and Williams, Gabrielle and McFall, David and Forcelli, Patrick A},
title = {Prophylactic senolytic treatment in aged mice reduces seizure severity and improves survival from Status Epilepticus},
journal = {Aging Cell},
year = {2024},
volume = {23},
number = {9},
doi = {10.1111/acel.14239}
}
EUVIMED